Viridian Therapeutics, Inc. (VRDN) total assets

Total assets · fiscal 2025
$899.42M

Viridian Therapeutics, Inc. (VRDN) had total assets of $899.42M at the end of fiscal 2025 (December 31, 2025). That is 21.1% higher than the $742.40M of fiscal 2024. Figures as of 18 Nov 2026, 00:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$899.42M
Change on fiscal 2024
+21.1%
Growth, 5 years
+46.9% a year
Growth, 10 years
+52.9% a year
Highest on record
$899.42Mfiscal 2025
Lowest on record
$3.67Mfiscal 2013
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Viridian Therapeutics, Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 46.9% a year; over ten years the rate was 52.9% a year. Across the 13 fiscal years on record (2013–2025), the highest was $899.42M in fiscal 2025 and the lowest $3.67M in fiscal 2013.

History · 13 fiscal years

Total assets by fiscal year

Viridian Therapeutics, Inc. total assets, year by year

Viridian Therapeutics, Inc. (VRDN) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$899.42M 21.1% up
2024$742.40M 51.4% up
2023$490.42M 12.7% up
2022$435.09M 113.6% up
2021$203.71M 55.2% up
2020$131.26M 333.7% up
2019$30.26M 54.3% down
2018$66.15M 26.0% up
2017$52.48M 112.0% up
2016$24.76M 91.9% up
2015$12.90M 59.5% up
2014$8.09M 120.2% up
2013$3.67M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on VRDN

Viridian Therapeutics, Inc., figure by figure

Viridian Therapeutics, Inc. (VRDN) overview: price, valuation and scorecard

Viridian Therapeutics, Inc. total assets: questions and answers

How large are Viridian Therapeutics, Inc.'s total assets?

Viridian Therapeutics, Inc. (VRDN) had total assets of $899.42M at the end of fiscal 2025 (December 31, 2025). That is 21.1% higher than the $742.40M of fiscal 2024.

What is the growth rate of Viridian Therapeutics, Inc.'s total assets?

Over the five fiscal years to 2025 total assets grew at a compound 46.9% a year; over ten years the rate was 52.9% a year.

What are the highest and lowest total assets figures on record for Viridian Therapeutics, Inc.?

Across the 13 fiscal years on record (2013–2025), the highest was $899.42M in fiscal 2025 and the lowest $3.67M in fiscal 2013.

How is Viridian Therapeutics, Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Viridian Therapeutics, Inc. (VRDN) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/VRDN/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.